EMD Millipore Direct Detect® and Muse™ Products Named as Finalists in 2013 American Business AwardsSM

  EMD Millipore Direct Detect® and Muse™ Products Named as Finalists in 2013
  American Business AwardsSM

  *Two EMD Millipore products will be recognized at 11th Annual Stevie®
    Awards on September 16 in San Francisco

Business Wire

BILLERICA, Mass. -- June 7, 2013

EMD Millipore, the Life Science division of Merck KGaA of Darmstadt, Germany,
was named a finalist in the New Product of the Year category of the 2013
American Business Awards for two products introduced this past year: the Muse™
Cell Analyzer and the Direct Detect® Protein Quantitation System. The awards
are given as a national recognition to new products that have impacted their
industries in significant ways.

Direct Detect(R) protein quantitation system (Photo: Business Wire)

Direct Detect(R) protein quantitation system (Photo: Business Wire)

“Our goal is to always help our customers perform better scientific research
and make progress towards the treatment, cure, and prevention of major
diseases. Both Muse™ and Direct Detect® products are faster and easier to use
than their traditional counterparts in these efforts, reducing workflow and
complexity,” said John Sweeney, Head of EMD Millipore’s Bioscience Business
Unit. "We are very proud to have these products recognized by the prestigious
American Business Awards this year.”

The Muse™ Cell Analyzer provides greater accuracy and precision than manual
hemocytometry or image-based automated analysis. Through real-time,
multi-dimensional information on cell populations, the Muse™ Cell Analyzer
enables faster, more accurate decision-making, more productive workflows and
greater insight in to cell health. Muse™ Cell Analyzer has allowed EMD
Millipore’s customers to run more samples in less time with greater accuracy.

The Direct Detect® system for rapid, simplified protein quantitation taps into
EMD Millipore’s membrane expertise to enable infrared-based measurement of
amide bonds in protein chains, an intrinsic component of every protein,
without relying on amino acid composition, dye-binding properties or redox
potential. The Direct Detect® system enables researchers to improve the speed
and accuracy of their quantitation, a necessary component of most downstream
applications.

More than 3,000 nominations from organizations of all sizes and virtually
every industry were submitted to The American Business Awards for
consideration in a wide range of categories, including Most Innovative Company
of the Year, Management Team of the Year, Best New Product or Service of the
Year, and Executive of the Year. Roughly 35% of submissions were named
finalists by a panel of more than 140 executives over five weeks of judging.
EMD Millipore’s Muse™ and Direct Detect® products are both finalists in the
New Product of the Year category for Health and Pharmaceutical Products, and
will ultimately receive either a Gold, Silver or Bronze “Stevie” Award in a
ceremony to be held in San Francisco on September 16.

Details about The American Business Awards and the list of Finalists in all
categories are available at http://www.stevieawards.com/aba

For more information on Muse™ and Direct Detect® products visit
www.millipore.com/directdetect and http://www.millipore.com/muse.

About EMD Millipore
EMD Millipore is the Life Science division of Merck KGaA of Germany and offers
a broad range of innovative, performance products, services and business
relationships that enable our customers' success in research, development and
production of biotech and pharmaceutical drug therapies. Through dedicated
collaboration on new scientific and engineering insights, and as one of the
top three R&D investors in the Life Science Tools industry, EMD Millipore
serves as a strategic partner to customers and helps advance the promise of
life science.

Headquartered in Billerica, Massachusetts, the division has around 10,000
employees, operations in 66 countries and 2012 revenues of €2.6 billion. EMD
Millipore is known as Merck Millipore outside of the U.S. and Canada.

Note: Merck KGaA or Merck shall mean Merck KGaA, Darmstadt, Germany

About Merck KGaA, Darmstadt, Germany
Merck KGaA, Darmstadt, Germany, is a global pharmaceutical, chemical and life
science company with total revenues of € 11.2 billion in 2012, a history that
began in 1668, and a future shaped by approx. 39,000 employees in 66
countries. Its success is characterized by innovations from entrepreneurial
employees. Merck KGaA's operating activities come under the umbrella of Merck
KGaA, Darmstadt, Germany, in which the Merck family holds an approximately 70%
interest and shareholders own the remaining approximately 30%. In 1917 the
U.S. subsidiary Merck & Co. was expropriated and has been an independent
company ever since.

Worldwide there are two separate companies that bear the name “Merck”, the
original Merck KGaA from Darmstadt, Germany, the oldest pharmaceutical and
chemical company in the world, and the pharmaceutical company Merck & Co. in
the United States. The rights to the name and trademark MERCK in North America
(USA and Canada) lie with Merck & Co., the former U.S. subsidiary of Merck,
whereas Merck KGaA operates in North America under the umbrella brand EMD. In
the rest of the world, Merck KGaA owns the rights to the Merck name and
trademark.

About the Stevie® Awards
Stevie® Awards are conferred in four programs: The American Business Awards,
The International Business Awards, the Stevie Awards for Women in Business,
and the Stevie® Awards for Sales & Customer Service. Honoring organizations of
all types and sizes and the people behind them, the Stevie® Awards recognize
outstanding performances in the workplace worldwide. Learn more about The
Stevie® Awards at www.stevieawards.com.

Photos/Multimedia Gallery Available:
http://www.businesswire.com/multimedia/home/20130607005630/en/

Multimedia
Available:http://www.businesswire.com/cgi-bin/mmg.cgi?eid=50648671&lang=en

Contact:

EMD Millipore
Cait Healey, +1 978-715-1663
Cait.Healey@emdmillipore.com